Literature DB >> 19944487

Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model.

Vikhyat S Bebarta1, David A Tanen, Julio Lairet, Patricia S Dixon, Sandra Valtier, Anneke Bush.   

Abstract

STUDY
OBJECTIVE: Cyanide can cause severe hypotension with acute toxicity. To our knowledge, no study has directly compared hydroxocobalamin and sodium nitrite with sodium thiosulfate in an acute cyanide toxicity model. Our objective is to compare the return to baseline of mean arterial blood pressure between 2 groups of swine with acute cyanide toxicity and treated with hydroxocobalamin with sodium thiosulfate or sodium nitrite with sodium thiosulfate.
METHODS: Twenty-four swine were intubated, anesthetized, and instrumented (continuous arterial and cardiac output monitoring) and then intoxicated with a continuous cyanide infusion until severe hypotension. The animals were divided into 2 arms of 12 each and then randomly assigned to intravenous hydroxocobalamin (150 mg/kg)+sodium thiosulfate (413 mg/kg) or sodium nitrite (10 mg/kg)+sodium thiosulfate (413 mg/kg) and monitored for 40 minutes after start of antidotal infusion. Twenty animals were needed for 80% power to detect a significant difference in outcomes (alpha 0.05). Repeated measures of analysis of covariance and post hoc t test were used for determining significance.
RESULTS: Baseline mean weights, time to hypotension (31 minutes 3 seconds versus 28 minutes 6 seconds), and cyanide dose at hypotension (5.6 versus 5.9 mg/kg) were similar. One animal in the hydroxocobalamin group and 2 animals in the sodium nitrite group died during antidote infusion and were excluded from analysis. Hydroxocobalamin resulted in a faster return to baseline mean arterial pressure, with improvement beginning at 5 minutes and lasting through the conclusion of the study (P<.05). No statistically significant difference was detected between groups for cardiac output, pulse rate, systemic vascular resistance, or mortality at 40 minutes post intoxication. Mean cyanide blood levels (4.03 versus 4.05 microg/mL) and lactate levels (peak 7.9 versus 8.1 mmol/L) at hypotension were similar. Lactate levels (5.1 versus 4.48 mmol/L), pH (7.40 versus 7.37), and base excess (-0.75 versus 1.27) at 40 minutes were also similar.
CONCLUSION: Hydroxocobalamin with sodium thiosulfate led to a faster return to baseline mean arterial pressure compared with sodium nitrite with sodium thiosulfate; however, there was no difference between the antidote combinations in mortality, serum acidosis, or serum lactate. Copyright (c) 2009 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944487     DOI: 10.1016/j.annemergmed.2009.09.020

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  12 in total

1.  Sodium Nitrite and Sodium Thiosulfate Are Effective Against Acute Cyanide Poisoning When Administered by Intramuscular Injection.

Authors:  Vikhyat S Bebarta; Matthew Brittain; Adriano Chan; Norma Garrett; David Yoon; Tanya Burney; David Mukai; Michael Babin; Renate B Pilz; Sari B Mahon; Matthew Brenner; Gerry R Boss
Journal:  Ann Emerg Med       Date:  2016-12-29       Impact factor: 5.721

2.  The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning.

Authors:  Adriano Chan; Daune L Crankshaw; Alexandre Monteil; Steven E Patterson; Herbert T Nagasawa; Jackie E Briggs; Joseph A Kozocas; Sari B Mahon; Matthew Brenner; Renate B Pilz; Timothy D Bigby; Gerry R Boss
Journal:  Clin Toxicol (Phila)       Date:  2011-06       Impact factor: 4.467

3.  Cyanide toxicity in juvenile pigs and its reversal by a new prodrug, sulfanegen sodium.

Authors:  Kumar G Belani; Harpreet Singh; David S Beebe; Preeta George; Steven E Patterson; Herbert T Nagasawa; Robert Vince
Journal:  Anesth Analg       Date:  2012-03-05       Impact factor: 5.108

4.  Acute electrocardiographic ST segment elevation may predict hypotension in a swine model of severe cyanide toxicity.

Authors:  Tylan A Muncy; Vikhyat S Bebarta; Shawn M Varney; Rebecca Pitotti; Susan Boudreau
Journal:  J Med Toxicol       Date:  2012-09

5.  In-vitro mercaptopyruvate sulfurtransferase species comparison in humans and common laboratory animals.

Authors:  Bryant M Moeller; Daune L Crankshaw; Jacquie Briggs; Herbert T Nagasawa; Steven E Patterson
Journal:  Toxicol Lett       Date:  2017-04-12       Impact factor: 4.372

6.  Intravenous cobinamide versus hydroxocobalamin for acute treatment of severe cyanide poisoning in a swine (Sus scrofa) model.

Authors:  Vikhyat S Bebarta; David A Tanen; Susan Boudreau; Maria Castaneda; Lee A Zarzabal; Toni Vargas; Gerry R Boss
Journal:  Ann Emerg Med       Date:  2014-04-18       Impact factor: 5.721

Review 7.  Case Files of the University of Massachusetts Toxicology Fellowship: Does This Smoke Inhalation Victim Require Treatment with Cyanide Antidote?

Authors:  Eike Hamad; Kavita Babu; Vikhyat S Bebarta
Journal:  J Med Toxicol       Date:  2016-06

Review 8.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

9.  Insufficient stocking of cyanide antidotes in US hospitals that provide emergency care.

Authors:  Lucas Gasco; Margaret B Rosbolt; Vikhyat S Bebarta
Journal:  J Pharmacol Pharmacother       Date:  2013-04

10.  Anti-colchicine Fab fragments prevent lethal colchicine toxicity in a porcine model: a pharmacokinetic and clinical study.

Authors:  Michael Eddleston; Nicolas Fabresse; Adrian Thompson; Ibrahim Al Abdulla; Rachael Gregson; Tim King; Alain Astier; Frederic J Baud; R Eddie Clutton; Jean-Claude Alvarez
Journal:  Clin Toxicol (Phila)       Date:  2018-01-15       Impact factor: 4.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.